Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fowzia Ibrahim
Cost-Effectiveness of Combination Disease-Modifying Antirheumatics vs. Tumour Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: TACIT Trial
Arthritis Care and Research
Rheumatology
Does Intensive Management Improve Remission Rates in Patients With Intermediate Rheumatoid Arthritis? (The TITRATE Trial): Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
Related publications
Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumour Necrosis Factor Α Inhibitors: Cohort Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Safety, Cost and Effectiveness Issues With Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Effect of Tumor Necrosis Factor Inhibitors on Interstitial Lung Disease in Rheumatoid Arthritis: Angel or Demon?
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-To-Target Strategy for Rheumatoid Arthritis
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
The Role of Cytokines in Predicting the Effectiveness of Combined Treatment With Tumor Necrosis Factor Α Inhibitors in Rheumatoid Arthritis
Tumour Necrosis Factor Gene Polymorphisms in Egyptian Patients With Rheumatoid Arthritis and Their Relation to Disease Activity and Severity
Central-European Journal of Immunology
Allergy
Immunology
Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis
International Journal of Inflammation
Allergy
Immunology
Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis
Journal of Managed Care Pharmacy
Evidence for Differential Acquired Drug Resistance to Anti-Tumour Necrosis Factor Agents in Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics